0001070081-17-000096.txt : 20170602 0001070081-17-000096.hdr.sgml : 20170602 20170602185435 ACCESSION NUMBER: 0001070081-17-000096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170531 FILED AS OF DATE: 20170602 DATE AS OF CHANGE: 20170602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Souza Marcio CENTRAL INDEX KEY: 0001707657 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 17889517 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 4 1 wf-form4_149644405900854.xml FORM 4 X0306 4 2017-05-31 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001707657 Souza Marcio C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 Chief Operating Officer Common Stock 2017-05-31 4 A 0 30000 0 A 36457 D Stock Option (Right To Buy) 12.53 2017-05-31 4 A 0 30000 12.53 A 2017-05-31 Common Stock 30000.0 30000 D Stock Option (Right To Buy) 26.42 2024-07-31 Common Stock 30000.0 30000 D Stock Option (Right To Buy) 51.0 2025-01-02 Common Stock 10525.0 10525 D Stock Option (Right To Buy) 30.86 2026-01-03 Common Stock 16000.0 16000 D Stock Option (Right To Buy) 12.64 2026-11-16 Common Stock 2000.0 2000 D Stock Option (Right To Buy) 11.23 2027-01-02 Common Stock 23100.0 23100 D Stock Option (Right To Buy) 12.92 2027-05-17 Common Stock 10000.0 10000 I By Spouse Restricted stock awarded to the Reporting Person vests in two equal annual installments over two years, commencing on May 31, 2018. This option was granted on May 31, 2017, and vests in two equal annual installments over two years, commencing on May 31, 2018. This option was granted on July 31, 2014 and vests over four years, with 25% of the shares underlying the option vested on July 31, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on October 31, 2015. This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vested on January 2, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2016. This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017. This option was granted on November 17, 2016, and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018. This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. This option was granted on May 17, 2017, and vests over four years, with 25% of the shares underlying the option vesting on May 8, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on August 8, 2018. Avraham S. Adler, attorney-in-fact 2017-06-02